Holliday junction recognition protein (HJURP), a centromere protein-A (CENP-A) histone chaperone, mediates centromere-specific assembly of CENP-A nucleosome, contributing to high-fidelity chromosome segregation during cell division. However, the role of HJURP in cellular senescence of human primary cells remains unclear. We found that the expression levels of HJURP decreased in human dermal fibroblasts and umbilical vein endothelial cells in replicative or premature senescence. Ectopic expression of HJURP in senescent cells partially overcame cell senescence. Conversely, downregulation of HJURP in young cells led to premature senescence. p53 knockdown, but not p16 knockdown, abolished senescence phenotypes caused by HJURP reduction. These data suggest that HJURP plays an important role in the regulation of cellular senescence through a p53-dependent pathway and might contribute to tissue or organismal aging and protection of cellular transformation.
N oRMAl somatic cells halt cell proliferation following a limited number of cell divisions (1) and enter a state termed cellular senescence due to telomere attrition. Diverse stress responses, including altered activity of oncogene and tumor suppressor gene, oxidative stress, DNA damage, inflammation, chemotherapeutic agents, and ultraviolet or gamma (γ) irradiation, are known to induce cellular senescence (2) . Besides growth arrest, other features of senescent cells include senescence-associated β-galactosidase (SA-β-gal) activity, DNA damage foci, and senescence-messaging secretome or senescence-associated secretory phenotypes (3) . Notwithstanding that diverse stress responses bring about cellular senescence, p53 and p16INK4A/Rb tumor suppressor pathways play a crucial role in the cell senescence process (4) . Many lines of evidence imply that cellular senescence contributes to tissue or organismal aging, tumor suppression or progression, tissue repair, and age-related pathology (3) .
Cells exhibit increasing errors in the mitotic machinery during senescence progress, leading to global changes in chromatin structure as well as genomic instability (5, 6) . Expression levels of centromere protein-F (CENP-F), mitotic kinesinlike protein-1, centromere protein-A (CENP-A), kinesinlike spindle protein, and mitotic centromere-associated kinase, which are involved in the regulation of chromosomal processing and assembly during cell divisions, are decreased in cells from middle age, old age, and progeria compared with cells from young human participants (7) . A variety of centrosomal and kinetochore proteins, such as Aurora-A, Aurora-B (8), TACC3, PCM1, pericentrin, p31comet (9) , CENP-A (10), Bub1, Bub3, BubR1 (11) , and Mad2 are linked to premature senescence via the tumor suppressor p53 (12) . loss of nucleosome remodeling and deacetylase chromatin remodeling complex was also reported to be involved in aging-related chromatin defects in premature and physiological aging (13) . Hutchinson-Gilford progeroid syndrome, caused by a de novo point mutation in the lamin A/C gene (lMNA), displays multiple chromosomal defects and continual DNA damage (14) . These reports suggest that chromosomal pathologies led by misregulation of mitotic genes might be involved in the aging process.
Holliday junction recognition protein (HJURP; URlC9, hFlEG9, DKFZp762E1312, FAKTS) as a CENP-A chaperone plays a critical role in centromere-specific assembly of CENP-A nucleosome (15, 16) . CENP-A, a centromeric-specific histone H3 variant, maintains the location of the centromeres and is also required in mitosis for nucleating the kinetochore, which is critical for high-fidelity chromosome segregation during cell division (17) . HJURP binds directly to soluble CENP-A, stabilizes CENP-A, and regulates the specific incorporation of CENP-A at centromeres during the G1 phase of cell cycle (18) . HJURP was originally identified to be overexpressed in lung cancers (19) . HJURP is upregulated via an ataxia telangiectasia mutated (ATM) signaling under DNA double-strand break response and involved in the homologous recombination pathway in the double-strand break repair process (19) . Depletion of HJURP revealed abnormal multilobed nuclei or micronuclei in Hela cells (15) and defects in chromosomal segregation in U2oS human osteosarcoma cells (16) resulting from a dramatic loss of CENP-A from centromeres. HJURP knockdown in U2oS cells leads to genomic instability and premature senescence with abnormal chromosome fusions (19) . Ectopic expression of HJURP also causes mitotic defects in Hela cells showing chromosome segregation errors (20) . In addition, HJURP expression was increased in EpsteinBarr virus-transformed lymphocytes (21) , suggesting its role in the promotion of cell cycle in normal cells. HJURP has been suggested to have clinical potential as a prognostic marker in lung cancers (19) , breast cancers (22) , gliomas (23) , bladder cancers, and melanomas (24) , and as a marker of radiation sensitivity in breast cancers (22, 25) . Recent studies on HJURP focused mainly in its role in cell cycle-specific maintenance and deposition of CENP-A at centeromeres and suggests that alteration of HJURP might be involved in chromosome instability related to cancer or aging. However, the role of HJURP in cellular senescence of human primary cells has not been reported yet.
This study investigated the causative effect of HJURP on cellular senescence in human primary cells. Downregulation of HJURP in young cells accelerated cellular senescence. In contrast, ectopic expression of HJURP in old cells partially rescued cell senescence. Knockdown of p53, but not p16, inhibited senescence phenotypes caused by HJURP repression. These data suggest that HJURP plays an important role in the regulation of cellular senescence in human primary cells through a p53-dependent pathway and might contribute to tissue or organismal aging and age-related pathology.
Methods
Human dermal fibroblasts (HDFs), human umbilical vein endothelial cells (HUVECs), and endothelial cell basal medium-2 supplemented with endothelial growth medium 2 were obtained from lonza (Walkersville, MD). Dulbecco's Modified Eagle's Medium (DMEM), fetal bovine serum, 100 U/ml of penicillin, and 100 µg/ml of streptomycin were purchased from Welegene (Daegu, Republic of Korea). Antibodies against HJURP, p53, p16, and glyceraldehyde-3-phosphate dehydrogenase were from Santa Cruz Biotechnology (Santa Cruz, CA). Horseradish peroxidaseconjugated secondary rabbit or mouse antibodies, Topo-TA cloning kit, lipofectamine 2000, plenti6/V5 directional ToPo cloning kit, small interfering RNAs (siRNAs) against HJURP (siHJURP#2, GACUCCUGGGCAUGAACAUG-UACA), p53 (sip53, UCCACACGCAAAUUUCCUUCCA-CUC), and p16 (sip16, CUACCGUAAAUGUCCAUUU) were from Invitrogen life Technologies (Carlsbad, CA). A plasmid mini extraction kit, siRNA against HJURP (siHJURP#1, CUACUGGGCUCAACUGCAAUU) and oligonucleotides for HJURP (380F, AGTCAGTTGCTT-GGGCCTTA; 615R, TGGGTCACCAGGACTCTTTC), p53 (forward, CCCTGAGGTTGGCTCTGA; reverse, GTGCTGAGCCT CCCCTTT), p16 (forward, CTTCCT-GGACACGCTGGT; reverse, ACCTTCCGCGGCATCTAT), and glyceraldehyde-3-phosphate dehydrogenase (forward, CGACCACTTTGTCAAGCTCA; reverse, AGGGGTCTA-CATGGCAACTG) were from Bioneer (Daejeon, Korea). Antibodies against p21, phospho-ATM (ser1981, pATM), CENP-A, phospho-H 2 AX (ser139, γH 2 AX), and phosphoRb (ser807/811, pRb) were purchased from Cell Signaling Technology Inc., (Beverly, MA). Agarose gel extraction kit was from SolGent (Daejeon, Republic of Korea). Bromochloro-indolyl-galactopyranoside (X-gal) was from Sigma-Aldrich (St. louis, Mo). Total RNA isolation solution was from Bio Science Technology (Daegu, Republic of Korea). Reverse transcription polymerase chain reaction (RT-PCR) kits were from Promega (Madison, WI) and Takara Biotechnology (Shiga, Japan).
cell culture
HDFs in DMEM and HUVECs in endothelial cell basal medium-2 supplemented with endothelial growth medium 2 were plated at 2 × 10 5 cells per 100-mm-diameter culture plate and cultured at 37°C in a 5% Co 2 humidified incubator. When subcultures reached 80% confluence, serial passaging was performed by trypsinization, and the number of population doublings was calculated using the geometric equation: Population doubling = log 2 F/log 2 i (F = final population number and i = initial population number). For the experiments, cells were used in either population doubling less than 24, or population doubling greater than 44, referred to as "young," or "old" or "senescent" cells, respectively.
induction of cellular Senescence by adriamycin
HDFs and HUVECs (2 × 10 5 cells) were seeded in 60-mm-diameter culture dishes and incubated for 24 hours in the particular culture medium. Cells were washed three times with DMEM and treated with 500 nM adriamycin for 4 hours. After discarding the medium-containing adriamycin, cells were washed three times with DMEM and incubated in culture medium for the indicated times.
cell counting
Cells were harvested by trypsin-EDTA treatment, stained with 0.1% trypan blue, and the cell number was determined using a hemocytometer.
Sa-β-Gal Staining
SA-β-gal activity in cells was observed as reported previously (26) . Cells were plated at 4 × 10 4 in 35-mm-diameter culture dishes, washed with phosphate-buffered saline (PBS), and fixed with 3.7% (v/v) paraformaldehyde in PBS for 3 minutes at room temperature. The presence of SA-β-gal activity was determined by incubating cells with a solution containing 40 mM citric acid-sodium phosphate (pH 6.0), 150 mM NaCl, 2 mM MgCl 2 , 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and 1 mg/ml X-gal for 17 hours at 37°C. The percentage of blue cells per 100 cells observed under a light microscope was determined.
Total Rna extraction and RT-PcR
RNAs were prepared from cells using a total RNA isolation solution according to the manufacturer's instructions. cDNAs were prepared from RNAs (1 µg) using 2.5 µM oligo-dT primers, 1 mM dNTPs, and Moloney murine leukemia virus reverse transcriptase. HJURP, p53, and p16 were amplified from cDNAs with Super-Therm DNA polymerase (SR Product, Kent, UK) and gene-specific oligonucleotides. Glyceraldehyde-3-phosphate dehydrogenase primers were used to estimate the amount of RNA in each sample. PCR products were separated on 1%-2% agarose gels, and the DNAs were visualized by Synergy Brands (SYBR) green staining with a lAS-3000 image system (Fujifilm life Science, Stamford, CT).
Protein extraction and Western Blot analysis
Cells were washed with PBS and lysed in 70 μl of radioimmunoprecipitation assay buffer (25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 1 mM sodium vanadate, 5 mM NaF, and protease inhibitor). The proteins were quantified by the bicinchoninic acid method using bovine serum albumin as a standard. Proteins (30 μg) were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred to nitrocellulose membranes. The membranes were incubated overnight at 4°C with specific antibody. After washing five times in Trisbuffered saline containing 1% Tween 20, horseradish peroxidase-conjugated secondary antibody was applied. The proteins were visualized using enhanced chemiluminescence with a lAS-3000 image system (Fujifilm life Science).
Preparation of plenti6/V5-HJURP Plasmids
A full-length HJURP cDNA was PCR amplified using RNA isolated from HDFs with HS DNA polymerase (Takara Biotechnology) and primers (forward, CACCATGCTGGGTACGCTGC and reverse, CACACTTTTAGTTTCCAATTTTTC). PCR products were purified using a gel extraction kit and ligated into a plenti6/V5-D-ToPo vector. Nucleotide sequences of a full-length HJURP cDNA in the plenti6/V5 vector (plenti6/V5-HJURP) were confirmed by dideoxy sequencing (SolGent).
Transfection of plenti6/V5-HJURP Plasmids
old HDFs or HUVECs were seeded in 60-mm dishes and incubated for 24 hours in DMEM or endothelial growth medium 2. Cells were then transfected with 1 µg of the plenti6/V5-HJURP plasmids or the plenti6/V5 plasmids as a control using the FuGene HD transfection reagent (Roche ltd, Basel, Switzerland) according to the manufacturer's protocol. After overnight incubation, fresh growth media were exchanged and cells were further incubated for 5 days.
Measurement of cell Proliferation by live-cell Time-lapse Microscopy
HDFs and HUVECs (1 × 10 3 cells) were seeded in 96-well plates and transfected with 1 µg of plenti6/V5-HJURP plasmids or plenti6/V5 plasmids for 24 hours. After discarding the media, cells were further incubated and observed with a leica ASMDW confocal microscope (leica Microsystems GmbH, Wetzlar, Germany) for 6 days. Cell numbers were determined by counting at the indicated times.
Transfection of siRnas
Young cells (2 × 10 5 ) were plated in 60-mm-diameter culture plates and incubated overnight. Cells were transfected with siRNA against HJURP, p53, or p16 using lipofectamine 2000 according to the manufacturer's protocol. After overnight incubation, fresh culture medium was added and transfected cells were cultured for 6 days in a Co 2 incubator.
Flow cytometry
Cells were harvested, washed twice with PBS, and fixed with 70% ethanol at −20°C for 1 hour. Following the washing of cells with PBS-containing 2% fetal bovine serum and 0.01% CaCl 2 , RNase (0.5 μg/ml) was added and incubated at 37°C for 30 minutes. Propidium iodide (50 μg/ml) was added and incubated for 20 minutes at room temperature. The intracellular propidium iodide fluorescence intensity of each population of 10,000 cells was measured in each sample using a BD FACSCanto II flow cytometer (BD Bioscience, San Jose, CA).
γH 2 aX immunofluorescence Staining
Cells were washed with ice-cold PBS, fixed with 3.7% (v/v) paraformaldehyde in PBS for 10 minutes, and permeabilized with 0.5% Triton X-100 in PBS for 5 minutes. A γH 2 AX antibody conjugated with Alexa Fluor 488 (Biolegend, San Diego, CA) was applied for 2.5 hour, and the nuclei were stained with 100 ng/ml of 4ʹ,6-diamidino-2-phenylindole. Cells were observed with a fluorescence microscope.
Statistical analysis
All data are presented as means ± SD. The two-tailed Student's t test was employed for all analyses and a p value less than .05 was considered statistically significant.
Results

Differential expression of HJURP in Young and old HDFs and HUVecs
Senescent cells are known to be resistant to proliferation, express SA-β-gal, and have a characteristically enlarged and flattened morphology. old HDFs and HUVECs showed senescent phenotypes that distinguished them from the early passage cells ( Figure 1A) . We examined the levels of HJURP expression in young and old HDFs and HUVECs by semiquantitative RT-PCR and Western blot analysis ( Figure 1B) . The expression level of HJURP mRNA was lower in old HDFs and HUVECs than in young cells. The HJURP protein level was also decreased in old HDFs and HUVECs. Furthermore, because cytotoxic agents such as adriamycin induce premature senescence (27) , we also measured the expression levels of HJURP in HDFs and HUVECs treated with adriamycin ( Figure 1C ). As expected, the HJURP protein level was decreased by adriamycin treatment. In addition, although the levels of pATM, p53, and p21 proteins were elevated, the pRb level was repressed in cells treated with adriamycin ( Figure 1C) .
inhibition of cellular Senescence by HJURP overexpression in old HDFs and HUVecs
To investigate the role of HJURP in cellular senescence, the levels of HJURP protein were upregulated in old cells by transfection with recombinant HJURP lentiviral plasmids (plenti6/V5-HJURP; Figure 2A ) and measured diverse senescence phenotypes. HJURP upregulation in old cells induced decreases in the levels of pATM, p53, and p21 proteins and an increase in the pRb level (Figure 2A ). Ectopic expression of HJURP in senescent cells increased cell proliferation in a time-dependent manner ( Figure 2B ) and resulted in morphological changes similar to young cells and a decrease in SA-β-gal staining activity ( Figure 2C ). Senescence-associated heterochromatic foci in the nucleus were also decreased by HJURP overexpression ( Figure 2D ). In addition, the upregulation of HJURP decreased the cell population in the G1 phase of the cell cycle, which is increased in old cells and cells with control vector and elevated the G2/M cell populations, which is declined in old cells and control vector ( Figure 2E ). However, there were no statistically significant differences in cell cycle profiles between control and HJURP overexpressing cells. These results imply that upregulation of HJURP in old cells partially rescued the senescence phenotypes.
acceleration of cellular Senescence by HJURP Knockdown in Young HDFs and HUVecs
Because upregulation of HJURP levels partially reversed cellular senescence, we examined the effects of HJURP knockdown on senescence phenotypes in young HDFs and HUVECs by transfection of HJURP siRNAs. HJURP knockdown was confirmed by RT-PCR and Western blotting ( Figure 3A) . Although the levels of pATM, p53, and p21 were elevated, the levels of pRb and CENP-A were repressed by HJURP knockdown ( Figure 3A) . Downregulation of HJURP decreased cell proliferation ( Figure 3B ) and increased SA-β-gal staining activity ( Figure 3C ). The γH 2 AX level was also increased in HJURP siRNA cells ( Figure 3D ). The G1 cell population of the cell cycle was increased, and the cell population in G2/M and S phases was decreased in HJURP siRNA cells ( Figure 3E ). However, we could not observe statistically significant differences in cell cycle profiles between control and HJURP siRNA cells. These data imply that downregulation of HJURP in young cells accelerates cellular senescence in HDFs and HUVECs.
induction of cellular Senescence by HJURP Through a p53-Dependent Pathway
The p53 and the p16INK4A/Rb tumor suppressor pathways play a critical role in the senescence response (4). To determine the pathway involved in the regulation of cellular senescence by HJURP reduction, we knocked down p53 or p16 levels in young cells and measured the effects of HJURP downregulation on cellular senescence. The levels of HJURP, p53, and p16 were confirmed by RT-PCR and Western blotting ( Figure 4A ). HJURP knockdown decreased cell proliferation in p16 siRNA cells but not in p53 siRNA cells ( Figure 4B) . Similarly, depletion of HJURP increased SA-β-gal staining activity in p16 siRNA cells but not in p53 siRNA cells ( Figure 4C ). Therefore, these results suggest that cellular senescence regulated by HJURP reduction is mediated through a p53-dependent pathway.
Discussion
In this study, we demonstrate that HJURP might play an important role in the regulation of cellular senescence in human primary cells based on the following findings: (a) the expression levels of HJURP reduced in cells under replicative or premature senescence induced by adriamycin ( Figure 1B and C) , (b) ectopic expression of HJURP in senescent cells partially overcame senescence phenotypes (Figure 2) , and (c) downregulation of HJURP in young cells induced premature senescence (Figure 3 ). HJURP depletion in U2oS cells was reported to induce genomic instability, resulting in premature cellular senescence with abnormal chromosome fusion (19) . Consistently, our findings that HJURP upregulation in old cells partially circumvented the senescence phenotypes and that HJURP knockdown in young cells accelerated cellular senescence suggests a causative role of HJURP in the regulation of cellular senescence in human primary cells. We showed that HJURP upregulation reduced the proportion of cells with G1 phase of cell cycle and increased S and G2/M population, suggesting a release of G1 arrest by HJURP overexpression ( Figure 2E ). In contrast, downregulation of HJURP in young primary cells increased the proportion of the cell population of G1 phase and decreased the proportions of the S and G2/M phases, suggesting G1 arrest by HJURP knockdown ( Figure 3E ). However, suppression of HJURP expression in U2oS osteosarcoma cells caused an increase in the G2/M phase population, suggesting G2/M arrest by HJURP depletion (19) . G1 or G2/M arrest of cell cycle is commonly observed during the progression of senescence depending on cell types and factors that induce senescence (28, 29) . Therefore, these differences might be partly due to the use of different cells. Upregulation of HJURP revealed mitotic defects in cancer cells (20) . We found ectopic expression of HJURP in old primary cells increased cell proliferation, released from G1 cell cycle arrest, and decreased SA-β-gal staining activity, suggesting recovery effects of HJURP on cell senescence. Because the level of HJURP is upregulated frequently in a variety of cancer cells (19, 22, 24) , additional expression of HJURP in cancer cells might cause mitotic defects due to early and premature chromosomal segregation. on the other hand, because the HJURP level decreased in primary cells as senescence progressed, forced expression of HJURP might restore its level in senescent cells, thereby leading to the rescue of senescence phenotypes. We found the levels of pATM and γH 2 AX were elevated in HJURP siRNA cells ( Figure 3A and D). Because pATM and γH 2 AX were activated by DNA damage response (30), our results suggest that HJURP knockdown might induce DNA damage response to activate the p53 pathway. It is well-known that p53 and p16INK4A/Rb tumor suppressor pathways play a critical role in the regulation of cellular senescence (4) . Therefore, we tried to demonstrate which tumor suppressor pathway played an important role in cell senescence induced by HJURP downregulation. We confirmed that the p53-dependent pathway might govern the regulation of cellular senescence induced by HJURP knockdown: (a) HJURP knockdown decreased cell proliferation in p16-shRNA-treated cells but not in p53-shRNAtreated cells (4B) and (b) HJURP knockdown increased SA-β-gal activity in p16-shRNA-treated cells but not in p53-shRNA-treated cells ( Figure 4C ). Consistently, diverse centrosomal and kinetochore proteins, such as Aurora-A, Aurora-B (8), Bub1, Bub3, BubR1 (11), CENP-A (10), Mad2, PCM1, p31comet (9), pericentrin, and TACC3 are involved in premature senescence via a p53 pathway (12) . HJURP was reported to be upregulated in cancer cells via an ATM signaling under DNA damage response by the exposure of γ-irradiation or DNA-damaging agents, such as camptothecin, cisplatin, and hydroxyurea (19) . Premature senescence caused by γ-irradiation (31) or hydroxyurea (32, 33) is mediated by ATM/p53 activation, thereby triggering the various p53-dependent signaling pathways (34) . Therefore, HJURP might be one of the target genes regulated by a p53-dependent pathway. However, our findings that HJURP expression was decreased in cells under replicative or premature senescence and that the p53 pathway was critical for the regulation of cellular senescence by HJURP suggest that HJURP expression in cellular senescence might be regulated via a p53 independent pathway because the p53 level was increased during cell senescence. Further studies would be necessary to elucidate the molecular mechanisms for HJURP expression in cell senescence. overall, our results revealed a causative role of HJURP in the regulation of cellular senescence of human primary cells. HJURP reduction as senescence progresses might induce growth arrest of cells with aberrant chromosomes, consequently contributing to the protection of cellular transformation.
